Wednesday, 21 June 2017

Nifty, Sensex Still on an uptrend – Wednesday closing report-The Total Investment & Insurance Solutions

Contact Your Financial Adviser Money Making MC
21 June 2017

I had mentioned in Tuesday’s closing report that Nifty, Sensex Nifty, Continues to be on an Uptrend. The major indices of the Indian stock markets were range-bound on Tuesday and closed with marginal losses over Tuesday’s close. The trends of the major indices in the course of Wednesday’s trading are given in the table below: The Total Investment & Insurance Solutions

Major Indices (The Total Investment & Insurance Solutions)

Engineering and construction major L&T rose on high volumes on reports the Government of India offloaded a part of its stake in the company via block deals today. According to reports the Government of India sold 2.5% stake in the company via block deals on the stock exchanges today, 21 June 2017. On the BSE, 2.39 crore shares were traded on the counter as against the average daily volumes of 1.97 lakh shares in the past one quarter. Most PSU bank stocks rose. Private bank stocks saw mixed trend. Most metal and mining stocks fell. 

Meanwhile, media reports suggested that ABB India is in discussions with L&T to acquire the latter's electrical and automation division. According to reports, ABB has offered over Rs 14000 crore for the deal and discussions are yet to arrive at a final figure. In a separate development, NHPC announced after market hours yesterday, 20 June 2017 that it has awarded EPC contract for the development of 50 megawatts (MW) Solar Power project in Tamil Nadu to L&T for an amount of Rs 287.48 crore. The project is slated to complete in 9 months.

Shares of aviation firm rose as crude oil prices extended recent losses. SpiceJet went up 4.03% and InterGlobe Aviation  gained 1.51%. The Total Investment & Insurance Solutions

Alembic Pharmaceuticals rose 2.28% after the company said that it has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application for Candesartan Cilexetil Tablets, 32 mg.  The approved ANDA is therapeutically equivalent to the reference listed drug product Atacand Tablets, 32 mg of AstraZeneca Pharmaceuticals LP. The drug is indicated in treatment of hypertension in adults and children and treatment of heart failure. Candesartan Cilexetil Tablets, 32 mg have an estimated market size of $27 million for twelve months ended December 2016. The Total Investment & Insurance Solutions

AstraZeneca Pharma India gained 1.62% after the report suggested that company received marketing authorisation from the Drug Controller General of India for Symbicort. Symbicort is indicated for treatment of severe asthma and for patients with moderate to severe chronic obstructive pulmonary disease (COPD) with frequent symptoms and a history of exacerbations, report added. The Total Investment & Insurance Solutions

ICICI Bank fell 0.53%. The company announced that the Committee of Executive Directors of the Bank at its meeting held on 20 June 2017 has approved the proposal for fund raising by way of issuance of senior unsecured long term bonds in the nature of debentures in single/multiple tranches on private placement basis. The announcement was made after market hours yesterday, 20 June 2017. The Total Investment & Insurance Solutions

Top Gainer (The Total Investment & Insurance Solutions)


The closing values of the major Asian indices are given in the table below: The Total Investment & Insurance Solutions
Asian Indices (The Total Investment & Insurance Solutions)

No comments:

Post a Comment